Nicholas Investment Partners, LP Lava Therapeutics Nv Transaction History

Nicholas Investment Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$2.28 - $4.4 $167,269 - $322,801	-73,364 Reduced 14.0%	450,556 $1.29 Million
Q4 2021 Feb 14, 2022	SELL	$4.23 - $7.77 $21,289 - $39,106	-5,033 Reduced 0.95%	523,920 $2.88 Million
Q3 2021 Nov 15, 2021	SELL	$5.5 - $11.0 $1.39 Million - $2.78 Million	-252,914 Reduced 32.35%	528,953 $3.13 Million
Q2 2021 Aug 10, 2021	SELL	$10.8 - $16.0 $356,108 - $527,568	-32,973 Reduced 4.05%	781,867 $8.51 Million
Q1 2021 May 14, 2021	BUY	$12.5 - $15.19 $10.2 Million - $12.4 Million	814,840 New	814,840 $12.4 Million

3.61M

32.9K

500

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $26.8M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.